{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:12:19Z","timestamp":1790169139455,"version":"4.1.0"},"reference-count":34,"publisher":"The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Med Sci"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3906\/sag-1609-49","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T06:19:23Z","timestamp":1510899563000},"page":"1642-1650","source":"Crossref","is-referenced-by-count":5,"title":["Exogenous erythropoietin aggravates retinal neovascularizationin a murine model of proliferative retinopathy"],"prefix":"10.55730","volume":"47","author":[{"given":"Ning","family":"YANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiao","family":"XING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"34691","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v5.i1.35"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.12860"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2015.1114847"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.10.006"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-007-9066-0"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000349936"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12049"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Aher SM, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 2014; 4: CD004868.","DOI":"10.1002\/14651858.CD004868.pub4"},{"key":"ref9","unstructured":"9. Rudzinska IM, Kornacka MK, Pawluch R. Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity. Przegl Lek 2002; 59 (Suppl. 1): 83-85 (in Polish with abstract in English)."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041773"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Romagnoli C, Tesfagabir MG, Giannantonio C, Papacci P. Erythropoietin and retinopathy of prematurity. Early Hum Dev 2011; 87 (Suppl. 1): S39-42.","DOI":"10.1016\/j.earlhumdev.2011.01.027"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2521"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2016.03.006"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2007.08.009"},{"key":"ref15","unstructured":"15. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D1397969521Amato R, Sullivan R, D1397969521Amore PA. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35: 101-111."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085824"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.187"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2014.47.11.009"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 2012; 10: CD004865.","DOI":"10.1002\/14651858.CD004865.pub3"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008; 118: 526-533.","DOI":"10.1172\/JCI33813"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181bc33e6"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.10.017"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000256"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.023"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011870"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.08.011"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25192"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Cassini-Vieira P, Araujo FA, da Costa Dias FL, Russo RC, Andrade SP, Teixeira MM, Barcelos LS. iNOS activity modulates inflammation, angiogenesis, and tissue fibrosis in polyether-polyurethane synthetic implants. Mediators Inflamm 2015; 2015: 138461.","DOI":"10.1155\/2015\/138461"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10874"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.04.004"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000110027"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-009-1066-x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.08.004"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000206468.18653.EC"}],"container-title":["TURKISH JOURNAL OF MEDICAL SCIENCES"],"original-title":[],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:19:12Z","timestamp":1655709552000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.tubitak.gov.tr\/medical\/vol47\/iss5\/46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3906\/sag-1609-49","relation":{},"ISSN":["1300-0144","1303-6165"],"issn-type":[{"value":"1300-0144","type":"print"},{"value":"1303-6165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}